Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings.

BACKGROUND We tested whether metabolic abnormalities in the prefrontal-striatal circuitry as demonstrated by positron emission tomography (PET) were present in patients seropositive for human immunodeficiency virus type 1 (HIV-1) with HIV-1-associated minor motor deficits as demonstrated by quantitative motor testing. PATIENTS We examined 19 HIV-1-positive patients, covering the range from normal results of quantitative motor testing to clearly pathologic psychomotor slowing indicative of HIV-1-associated minor motor deficits. None fulfilled the clinical criteria for HIV-1-associated dementia. Results were compared with those of 15 healthy volunteers. METHODS All subjects underwent clinical examination, routine magnetic resonance (MR) imaging, and electrophysiologic motor testing at the time of PET. RESULTS Seven HIV-1-positive patients showed significant hypermetabolism in the basal ganglia. Nine patients showed a significant frontomesial hypometabolism. CONCLUSIONS The data of our cross-sectional study strongly suggest a characteristic time course in the development of HIV-1-associated minor motor deficits. Hypermetabolism in the basal ganglia is associated initially with normal motor performance. Moderate motor slowing appears at a later stage when basal ganglia hypermetabolism drops toward hypometabolism. More severe functional deficits and highly pathologic motor slowing become manifest when hypometabolism is most widespread in the basal ganglia. This stage leads to dementia.

[1]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[2]  E. Hoffman,et al.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.

[3]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[4]  E. Hoffman,et al.  Noninvasive determination of local cerebral metabolic rate of glucose in man. , 1980, The American journal of physiology.

[5]  C. Markham,et al.  Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.

[6]  W. Snider,et al.  Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients , 1983, Annals of neurology.

[7]  C. D. Arnett,et al.  Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[9]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.

[10]  B. Navia,et al.  The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.

[11]  H. Freund,et al.  Impairment of rapid movement in Huntington's disease. , 1987, Brain : a journal of neurology.

[12]  S. Strother,et al.  The metabolic pathology of the AIDS dementia complex , 1987, Annals of neurology.

[13]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[14]  E. Rota Kops,et al.  Performance characteristics of an eight-ring whole body PET scanner. , 1990, Journal of computer assisted tomography.

[15]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[16]  H. Freund,et al.  Neurophysiology of fastest voluntary muscle contraction in hereditary neuropathy , 1990, Annals of neurology.

[17]  P. Lantos,et al.  HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology , 1991, Brain pathology.

[18]  Andrew J. Saykin,et al.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.

[19]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[20]  H. Freund,et al.  Improvement of motor performance of HIV‐positive patients under AZT therapy , 1992, Neurology.

[21]  C. Stern,et al.  Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[22]  H. Freund,et al.  Motor impairment in Wilson's disease, I: slowness of voluntary limb movements , 1993, Acta neurologica Scandinavica.

[23]  C. Petito.  What causes brain atrophy in human immunodeficiency virus infection? , 1993, Annals of neurology.

[24]  H. Freund,et al.  The role of basal ganglia in rhythmic movement. , 1993, Advances in neurology.

[25]  H. Freund,et al.  Motor analysis predicts progression in HIV-associated brain disease , 1994, Journal of the Neurological Sciences.

[26]  H. Freund,et al.  Remote depressions of cerebral metabolism in hemiparetic stroke: Topography and relation to motor and somatosensory functions , 1994 .

[27]  G. Triebig,et al.  Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence , 1995, Acta neurologica Scandinavica.

[28]  M. Gee,et al.  Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[29]  S C Strother,et al.  Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  D R Hoover,et al.  Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. , 1996, Journal of neurovirology.

[31]  M. O'Doherty,et al.  PET scanning and the human immunodeficiency virus-positive patient. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  A. Nath,et al.  HIV dementia and the basal ganglia. , 1997, Intervirology.

[33]  O. Selnes,et al.  Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men , 1999, Neurology.

[34]  J. Raven.  The Raven's Progressive Matrices: Change and Stability over Culture and Time , 2000, Cognitive Psychology.